Table 3 Vital signs and lab. differences among the studied COVID-19 patients
From: Acute kidney injury in hospitalized patients with COVID-19 (retrospective study)
Parameter | All (n = 86) | AKI (n = 61) | Non-AKI (n = 25) | P value* |
|---|---|---|---|---|
Vital signs | ||||
• SBP (mmHG) | 120 (70–210) | 140 (100–210) | 120 (70–170) | 0.089 |
• DBP (mmHG) | 80 (50–110) | 80 (50–110) | 80 (60–100) | 0.362 |
• PH | 7.41 (7.3–7.6) | 7.43 (7.3–7.5) | 7.38 (7.5–7.6) | 0.658 |
• PCO2 | 31 (20–62) | 34 (25–56) | 26 (20–62) | 0.112 |
• PO2 | 87 (28–230) | 80.5 (28–224) | 91 (85–230) | 0.044 |
• SO2 | 98 (46–100) | 95 (46–100) | 99 (80–100) | 0.041 |
Laboratory findings | ||||
• WBCs (103/μl) | 10 (3.5–27) | 10 (3.5–27) | 9.5 (8–15) | 0.684 |
• Lymphocyte (%) | 14 (2.5–55) | 13 (3–22) | 15 (2.5–50) | 0.041 |
• Hgb (g/dl) | 12 (5–15) | 11.5 (5–15) | 12.5 (11–14) | 0.046 |
• Platelet (103/l) | 266 (110–727) | 207 (110–727) | 266 (115–624) | 0.025 |
• Neutrophil (%) | 75 (22–94) | 78 (28–94) | 72 (28–86) | 0.215 |
• BUN (mg/dl) | 11 (1–176) | 17 (9–176) | 7 (1–85) | 0.005 |
• S. creatinine | 0.5 (0.01–6.25) | 0.7 (0.02–6.25) | 0.2 (0.01–0.1) | 0.011 |
• AST (U/l) | 31 (16–423) | 35 (27–423) | 29 (16–114) | 0.098 |
• ALT (U/l) | 31 (5–312) | 28 (5–312) | 34 (5–84) | 0.033 |
• T. bilirubin (mg/dl) | 8 (0.5–45) | 10 (2–45) | 4 (0.5–20) | 0.045 |
• Albumin (g/dl) | 3.7 (0.1–5.1) | 3.4 (0.2–5.1) | 3.9 (0.1–4.5) | 0.016 |
• PT | 15 (9–45) | 13 (11–45) | 14 (9–18) | 0.146 |
• PC% | 93 (18–124) | 92 (18–124) | 95 (75–100) | 0.245 |
• INR | 1.01 (0.7–4.6) | 1.04 (0.9–4.6) | 0.82 (0.7–1.1) | 0.040 |
• CRP (IU/ml) | 44 (6–99) | 46 (6–99) | 38 (10–83) | 0.049 |
• Ferritin (ng/ml) | 612 (76–6543) | 659 (76–6543) | 409 (125–903) | 0.003 |
• D-dimer (ng/ml) | 5946 (98–13,470) | 6789 (356–13,470) | 2345 (98–9876) | 0.001 |